Evogene (EVGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.70M
Last updated: Nov 17, 2026 at 4:39 PM ET
Evogene (EVGN) Stock Chart
Evogene (EVGN) has a latest price of $0.34 on Nov 17, 2026, 73.0% below its 52-week high of $1.26. Its price fell 71.9% over the past 12 months. The month-end price fell 99.4% over the 10 years through Oct 2026, a compound annual decline of 39.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $61.20 in Jan 2021 and its lowest $0.37 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart EVGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for EVGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 43.4%, and over 6 months it fell 54.3%. The month-end price fell 92.2% over the 3 years through Oct 2026, a compound annual decline of 57.2%.
| Period | Change |
|---|---|
| 1 month | -7.6% |
| 3 months | -43.4% |
| 6 months | -54.3% |
| 12 months | -71.9% |
| 12 months, with dividends | -71.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -92.2% | -57.2% |
| 5 years | -98.6% | -57.2% |
| 10 years | -99.4% | -39.8% |
Price by Year
Its best calendar year was 2020, when the price rose 209.2%, and its weakest was 2024, when it fell 77.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.37 | -65.9% |
| 2025 | $1.10 | -41.2% |
| 2024 | $1.87 | -77.7% |
| 2023 | $8.40 | +20.0% |
| 2022 | $7.00 | -57.3% |
| 2021 | $16.40 | -65.1% |
| 2020 | $47.00 | +209.2% |
| 2019 | $15.20 | -23.2% |
| 2018 | $19.80 | -35.5% |
| 2017 | $30.70 | -39.8% |
Trading Range
The price is 15.6% below its 50-day average of $0.40 and 45.4% below its 200-day average of $0.62.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.34 | |
| 52-week high | $1.26 | -73.0% |
| 52-week low | $0.25 | +36.0% |
| 50-day average | $0.40 | -15.6% |
| 200-day average | $0.62 | -45.4% |
Price Risk
Over 3 years, its largest fall from a peak was 97.2%.
| Measure | Value |
|---|---|
| 1-year beta | 1.29 |
| Largest fall, 1 year | -77.4% |
| Largest fall, 3 years | -97.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About EVGN
What is EVGN's 1-year price change?
Evogene's price fell 71.9% over the past 12 months. With dividends included, the 12-month total return was -71.9%.
What is EVGN's 5-year price change?
Evogene's month-end price fell 98.6% over the 5 years through Oct 2026, a compound annual decline of 57.2%. These figures leave out dividends.
What is EVGN's 52-week high and low?
Evogene's 52-week high is $1.26 and its 52-week low is $0.25. Its latest price of $0.34 on Nov 17, 2026 is 73.0% below the high.
What is EVGN's beta?
Evogene's 1-year beta against the S&P 500 is 1.29, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 77.4%.
Is the EVGN chart free?
Yes. Advanced Charting for EVGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
EVGN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors